CS Analytical RM Analytical launch marks a major expansion in pharmaceutical raw material and finished product testing. CS Analytical has introduced Raw Material Analytical to strengthen its capabilities for pharmaceutical, biopharmaceutical, and related industries.
With this move, CS Analytical positions itself as a comprehensive, one-stop analytical partner for manufacturers operating under strict global regulatory requirements. As regulatory scrutiny increases, reliable and compliant testing services become even more critical.
Expanding Pharmaceutical Raw Material and Finished Product Testing
The CS Analytical RM Analytical launch expands testing capabilities for both raw materials and finished pharmaceutical products. Importantly, the laboratory now supports testing aligned with major global compendial standards, including USP, EP, JP, BP, ChP, and ACS.
As a result, manufacturers can streamline testing across multiple regulatory frameworks. In addition, the expanded services allow CSA to manage higher testing volumes while maintaining strong scientific rigor and data integrity.
This growth also enhances regulatory compliance support throughout the product lifecycle, from incoming raw materials to final product release.
Advanced Laboratory Infrastructure and Scientific Expertise
To support the RM Analytical expansion, CS Analytical has strengthened its laboratory infrastructure and upgraded its instrumentation. Consequently, clients benefit from faster turnaround times without compromising accuracy or reliability.
Moreover, CSA’s team includes experienced scientists with advanced degrees in chemistry and extensive industry expertise. Their technical knowledge ensures precise analytical results that meet both routine and specialized testing needs.
The expanded portfolio now covers non-compendial and client-specific methods, providing flexibility for complex pharmaceutical requirements.
Leadership Highlights Commitment to Quality
Brandon Zurawlow, Chief Operating Officer at CS Analytical, emphasized that the expanded testing portfolio enables the company to support both routine and specialized analytical services. He noted that these capabilities help clients meet strict quality and regulatory expectations efficiently.
Similarly, Ronak Patel, Director of Analytical Services – Raw Materials and Finished Products, reinforced the company’s commitment to delivering precise and timely analytical data. According to Patel, this expansion reflects CSA’s ongoing effort to raise the bar for analytical excellence.
Strengthening End-to-End Regulatory Support
Beyond raw material and finished product testing, CS Analytical remains a leader in container and package qualification testing. The FDA-regulated, cGMP laboratory specializes in complex drug and medical device container systems, including container closure integrity (CCI) testing and USP <1207> services.
Therefore, the CS Analytical RM Analytical launch strengthens the company’s role as a full-spectrum analytical partner. By integrating expanded pharmaceutical testing with established regulatory expertise, CSA helps manufacturers ensure quality, safety, and compliance across global markets.
Read Also: Retevmo Adjuvant Therapy Improves Event-Free Survival in RET+ NSCLC
